Digenic DUOX1 and DUOX2 mutations in cases with congenital hypothyroidism


Creative Commons License

Aycan Z., Cangul H., Muzza M., Bas V. N., Fugazzola L., Chatterjee V. K., ...Daha Fazla

Journal of Clinical Endocrinology and Metabolism, cilt.102, sa.9, ss.3085-3090, 2017 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 102 Sayı: 9
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1210/jc.2017-00529
  • Dergi Adı: Journal of Clinical Endocrinology and Metabolism
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.3085-3090
  • İstanbul Medipol Üniversitesi Adresli: Evet

Özet

Context: The DUOX2 enzyme generates hydrogen peroxide (H2O2), a crucial electron acceptor for the thyroid peroxidase-catalyzed iodination and coupling reactions mediating thyroid hormone biosynthesis. DUOX2 mutations result in dyshormonogenetic congenital hypothyroidism (CH) that may be phenotypically heterogeneous, leading to the hypothesis that CH severity may be influenced by environmental factors (e.g., dietary iodine) and oligogenic modifiers (e.g., variants in the homologous reduced form of NAD phosphate-oxidase DUOX1). However, loss-of-function mutations in DUOX1 have not hitherto been described, and its role in thyroid biology remains undefined. Case Description: We previously described a Proband and her brother (P1, P2) with unusually severe CH associated with a DUOX2 homozygous nonsense mutation (p.R434∗); P1, P2: thyrotropin .100 mU/mL [reference range (RR) 0.5 to 6.3]; and P1: free T4 (FT4) ,0.09 ng/dL (RR 0.9 to 2.3). Subsequent studies have revealed a homozygous DUOX1 mutation (c.1823-1G.C) resulting in aberrant splicing and a protein truncation (p.Val607Aspfs∗43), which segregates with CH in this kindred. Conclusion: This is a report of digenic mutations in DUOX1 and DUOX2 in association with CH, and we hypothesize that the inability of DUOX1 to compensate for DUOX2 deficiency in this kindred may underlie the severe CH phenotype. Our studies provide evidence for a digenic basis for CH and support the notion that oligogenicity as well as environmental modulators may underlie phenotypic variability in genetically ascertained CH.